USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Glykos Finland OY

USPTO PatentsView assignee record - 21 granted patents across 13 technology areas, recorded in grant years 2016–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

RSS updates for this company

The verdict

According to USPTO PatentsView, Glykos ranks #14,011 of 49,997 tracked US assignees by granted-patent volume, with 21 patents across 13 technology areas.

#14,011
of 49,997 US assignees by volume
43rd percentile
by Innovation Score (32.9/100)
13.7
avg claims per patent
-9%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R14011 · Foreign Corporation #14,011 · 21 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

  • GRANTS-SMALL 21 grants
  • MID-PACK #14,011/49,997
  • PHOTO-FINISH GIESECKE+DEVRIENT…
  • CPC-FOCUS C12N · 13 areas
  • INNOV-THIN 32.9/100
  • CLAIMS-RICH 13.7 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-FLAT -9% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: GIESECKE+DEVRIENT Epayments GMBH (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Glykos’s 32.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Glykos

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Glykos's Innovation Score is 32.9/100 (43rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Glykos?

Each dot is one of Glykos’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Glykos’s own 13.7 claims/patent is ABOVE the 12.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Glykos vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 20.920.92121.1 010203040 Granted patents (volume) Avg claims / patent GIESECKE+DEVRIENT Epayments GMBH - 21, 14.76Giesecke+Devrient…Giftedness AND Creativity Company - 21, 12.05Giftedness AND Cr…Globegou WZ Co., Ltd. - 21, 1Globegou WZGlycomimetics, Inc. - 21, 32.57GlycomimeticsGM Global Technologies Operations LLC - 21, 13.24GM Global Operati…Grant Prideco, Inc. - 21, 17.19Grant PridecoGravitron, LLC - 21, 6.48GravitronGreenleaf Nursery Co. - 21, 1Greenleaf NurseryGlykos Finland OY - 21, 13.71Glykos Finland OY
Glykos vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Glykos's grants concentrate

Glykos Finland OY is a focused PatentsView assignee: 13 CPC subclasses with 71.4% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2016 (5 grants) versus a trough of 1 in 2018. By volume, Glykos sits between GIESECKE+DEVRIENT Epayments GMBH and Greenleaf Nursery Co..

Glykos's three-year grant acceleration

Glykos Finland OY shows 2 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Glykos's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Glykos holds 21 patents at rank #14,004, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Glykos

By rank, the assignees closest to #14,004 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Glykos's primary technology class.

Glykos's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 43rd percentile higher than 43% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 2016201720182019202020212023 2
USPTO utility patent grants by year · 2016–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Glykos Finland OY patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 5 23.8%
2017 2 9.5%
2018 1 4.8%
2019 3 14.3%
2020 4 19.0%
2021 4 19.0%
2023 2 9.5%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Glykos Finland OY's patent record in context - here's where to go next.

  • Glykos Finland OY's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 71.4% of its portfolio - see every assignee active in that class. Explore C12N
  • Ranked #14,011 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Glykos Finland OY against GIESECKE+DEVRIENT Epayments GMBH, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 32.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.